FDA 483 - Joinn Laboratories Co. Ltd. - May 21, 2024

An FDA inspection of Joinn Laboratories Co. Ltd. in Beijing, China, a nonclinical laboratory, revealed two significant observations. The firm was cited for failing to adequately validate equipment used for data generation and for the quality assurance unit's failure to identify and document deviations from approved protocols.